Characteristic | Training dataset (N = 61) | Testing dataset (N = 25) | P value | External dataset (N = 26) |
---|---|---|---|---|
Age,median (range)years | 50(33–74) | 51(40–58) | 0.970 | 52(40–74) |
FIGO stage, No. (%) | ||||
 Ia | 18(29.50) | 4(16.00) |  | 5(19.23) |
 Ib | 26(42.60) | 10(40.00) |  | 12(46.15) |
 IIa | 17(27.90) | 11(44.00) |  | 9(34.62) |
Tumor grade, No. (%) | Â | Â | 0.085 | Â |
 Well differentiate | 14(23.00) | 6(24.00) |  | 6(23.08) |
 Moderately differentiate | 29(47.50) | 17(68.00) |  | 15(57.69) |
 Poorly differentiate | 18(29.50) | 2(8.00) |  | 5(19.23) |
Depth of cervical stromal tumor invasion, No. (%) | Â | Â | 0.605 | Â |
  ≥ 1/2 | 43(70.50) | 19(76.00) |  | 21(80.77) |
 <1/2 | 18(29.50) | 6(24.00) |  | 5(19.23) |
LVSI, No. (%) | Â | Â | 0.921 | Â |
 Yes | 30(49.20) | 12(48.00) |  | 15(57.69) |
 No | 31(50.80) | 13(52.00) |  | 11(42.31) |
COX-2 expression No. (%) | Â | Â | 0.400 | Â |
 Negative or Weak-Positive | 28(45.90) | 11(44.00) |  | 11(42.31) |
 Moderate-Positive | 22(36.10) | 12(48.00) |  | 10(38.46) |
 Strong-Positive | 11(18.00) | 2(8.00) |  | 5(19.23) |
TNC expression No. (%) | Â | Â | 0.975 | Â |
 Negative or Weak-Positive | 40(65.60) | 17(68.00) |  | 19 (73.08) |
 Moderate-Positive | 16(26.20) | 6(24.00) |  | 6(23.08) |
 Strong-Positive | 5(8.20) | 2(8.00) |  | 1(3.85) |